Activating transcription factor 4, an ER stress mediator, is required for, but excessive ER stress suppresses osteoblastogenesis by bortezomib

Search this Article

Author(s)

    • NAKAMURA Shingen
    • Department of Medicine and Bioregulatory Sciences, University of Tokushima Graduate School of Medicine
    • MIKI Hirokazu
    • Department of Transfusion Medicine, Tokushima University Hospital
    • KIDO Shinsuke
    • Department of Molecular Nutrition, Institute of Health Biosciences, University of Tokushima Graduate School
    • NAKANO Ayako
    • Department of Medicine and Bioregulatory Sciences, University of Tokushima Graduate School of Medicine
    • HIASA Masahiro
    • Department of Biomaterials and Bioengineerings, University of Tokushima Graduate School of Oral Sciences
    • ODA Asuka
    • Department of Medicine and Bioregulatory Sciences, University of Tokushima Graduate School of Medicine
    • AMOU Hiroe
    • Department of Medicine and Bioregulatory Sciences, University of Tokushima Graduate School of Medicine
    • KAGAWA Kumiko
    • Department of Medicine and Bioregulatory Sciences, University of Tokushima Graduate School of Medicine
    • OZAKI Shuji
    • Divesion of Internal Medicine, Tokushima Prefectural Central Hospital, Tokushima, Japan
    • MATSUMOTO Toshio
    • Department of Medicine and Bioregulatory Sciences, University of Tokushima Graduate School of Medicine

Journal

  • International journal of hematology

    International journal of hematology 98(1), 66-73, 2013-07-01

References:  41

Codes

  • NII Article ID (NAID)
    10031189598
  • NII NACSIS-CAT ID (NCID)
    AA10797094
  • Text Lang
    ENG
  • Article Type
    ART
  • ISSN
    09255710
  • Data Source
    CJP 
Page Top